Lunai Bioworks Inc. (LNAI) — Institutional Holders, Q2 2026

16 institutional investment managers reported a LNAI position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $641.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

LNAI 13F holders ranked 1–16 of 16

Institutional investors reporting a position in Lunai Bioworks Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Ground Swell Capital#1 · 53,211 sh$174.0KNew
STATE STREET#2 · 37,537 sh$122.7K+5.1%
GEODE CAPITAL MANAGEMENT#3 · 24,156 sh$79.0K-86.7%
JANE STREET GROUP#4 · 23,683 sh$77.4KNew
VANGUARD CAPITAL MANAGEMENT#5 · 16,081 sh$52.6KNew
BlackRock#6 · 15,906 sh$52.0K-87.5%
Virtu Financial#7 · 12,863 sh$42.0K-82.9%
VANGUARD FIDUCIARY#8 · 8,642 sh$28.3KNew
ROYAL BANK OF CANADA#9 · 1,687 sh$5.0K+417.5%
Tower Research Capital (TRC)#10 · 1,405 sh$4.6K-70.1%
GROUP ONE TRADING, L.P.#11 · 544 sh$1.8K-87.5%
MORGAN STANLEY#12 · 326 sh$1.1K-87.5%
COMPASS FINANCIAL MANAGEMENT#13 · 125 sh$409.00—
BNP PARIBAS FINANCIAL MARKETS#14 · 24 sh$78.00-85.1%
JPMORGAN CHASE#15 · 6 sh$19.00-92.6%
DEUTSCHE BANK AG\#16 · 1 sh$3.000.0%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.